Vanholder R - Search Results

1

Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma.

Tijink MS, Wester M, Glorieux G, Gerritsen KG, Sun J, Swart PC, Borneman Z, Wessling M, Vanholder R, Joles JA, Stamatialis D. Tijink MS, et al. Among authors: vanholder r. Biomaterials. 2013 Oct;34(32):7819-28. doi: 10.1016/j.biomaterials.2013.07.008. Epub 2013 Jul 19. Biomaterials. 2013. PMID: 23876759

2

New low-flux mixed matrix membranes that offer superior removal of protein-bound toxins from human plasma.

Pavlenko D, van Geffen E, van Steenbergen MJ, Glorieux G, Vanholder R, Gerritsen KG, Stamatialis D. Pavlenko D, et al. Among authors: vanholder r. Sci Rep. 2016 Oct 5;6:34429. doi: 10.1038/srep34429. Sci Rep. 2016. PMID: 27703258 Free PMC article.

3

New uremic toxins - which solutes should be removed?

Glorieux G, Vanholder R. Glorieux G, et al. Among authors: vanholder r. Contrib Nephrol. 2011;168:117-128. doi: 10.1159/000321750. Epub 2010 Oct 7. Contrib Nephrol. 2011. PMID: 20938131 Review.

4

Association between Protein-Bound Uremic Toxins and Asymptomatic Cardiac Dysfunction in Patients with Chronic Kidney Disease.

Chinnappa S, Tu YK, Yeh YC, Glorieux G, Vanholder R, Mooney A. Chinnappa S, et al. Among authors: vanholder r. Toxins (Basel). 2018 Dec 5;10(12):520. doi: 10.3390/toxins10120520. Toxins (Basel). 2018. PMID: 30563136 Free PMC article.

5

An update on protein-bound uremic retention solutes.

Vanholder R, Schepers E, Pletinck A, Neirynck N, Glorieux G. Vanholder R, et al. J Ren Nutr. 2012 Jan;22(1):90-4. doi: 10.1053/j.jrn.2011.10.026. J Ren Nutr. 2012. PMID: 22200422 Review.

6

Does the adequacy parameter Kt/V(urea) reflect uremic toxin concentrations in hemodialysis patients?

Eloot S, Van Biesen W, Glorieux G, Neirynck N, Dhondt A, Vanholder R. Eloot S, et al. Among authors: vanholder r. PLoS One. 2013 Nov 13;8(11):e76838. doi: 10.1371/journal.pone.0076838. eCollection 2013. PLoS One. 2013. PMID: 24236005 Free PMC article.

7

The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.

Vanholder R, Schepers E, Pletinck A, Nagler EV, Glorieux G. Vanholder R, et al. J Am Soc Nephrol. 2014 Sep;25(9):1897-907. doi: 10.1681/ASN.2013101062. Epub 2014 May 8. J Am Soc Nephrol. 2014. PMID: 24812165 Free PMC article. Review.

8

Evolution of protein-bound uremic toxins indoxyl sulphate and p-cresyl sulphate in acute kidney injury.

Veldeman L, Vanmassenhove J, Van Biesen W, Massy ZA, Liabeuf S, Glorieux G, Vanholder R. Veldeman L, et al. Among authors: vanholder r. Int Urol Nephrol. 2019 Feb;51(2):293-302. doi: 10.1007/s11255-018-2056-x. Epub 2019 Jan 2. Int Urol Nephrol. 2019. PMID: 30604232

9

What is new in uremic toxicity?

Vanholder R, Van Laecke S, Glorieux G. Vanholder R, et al. Pediatr Nephrol. 2008 Aug;23(8):1211-21. doi: 10.1007/s00467-008-0762-9. Epub 2008 Mar 7. Pediatr Nephrol. 2008. PMID: 18324423 Free PMC article. Review.

10

A novel UPLC-MS-MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients.

Boelaert J, Lynen F, Glorieux G, Eloot S, Van Landschoot M, Waterloos MA, Sandra P, Vanholder R. Boelaert J, et al. Among authors: vanholder r. Anal Bioanal Chem. 2013 Feb;405(6):1937-47. doi: 10.1007/s00216-012-6636-9. Epub 2013 Jan 11. Anal Bioanal Chem. 2013. PMID: 23307120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

872 results

Search Page